Compare INUV & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INUV | DYAI |
|---|---|---|
| Founded | N/A | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.0M | 17.0M |
| IPO Year | 1996 | 2026 |
| Metric | INUV | DYAI |
|---|---|---|
| Price | $0.58 | $0.43 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $3.50 | N/A |
| AVG Volume (30 Days) | 132.5K | ★ 190.2K |
| Earning Date | 11-05-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $86,209,305.00 | $3,090,345.00 |
| Revenue This Year | N/A | $113.16 |
| Revenue Next Year | $12.51 | $94.92 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 2.88 | N/A |
| 52 Week Low | $0.47 | $0.34 |
| 52 Week High | $3.80 | $1.60 |
| Indicator | INUV | DYAI |
|---|---|---|
| Relative Strength Index (RSI) | 34.99 | 36.11 |
| Support Level | $0.57 | $0.34 |
| Resistance Level | $0.61 | $0.87 |
| Average True Range (ATR) | 0.04 | 0.06 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 64.42 | 62.48 |
Inuvo Inc is an advertising technology and services company that has developed and commercialized large language generative artificial intelligence (AI) for modeling media audiences. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.